Emergency Med Medical News about Menstrual Cycle Migraine Disorders Frovatriptan

Your Unread Messages

See All

Hello, Mary O'connor
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Safety and Tolerability of Short-Term Preventive Frovatriptan: A Combined Analysis
Headache: The Journal of Head and Face Pain, 10/14/09

MacGregor AE et al. – During treatment of up to 12 perimenstrual periods over a 12– to 15–month period, the safety and tolerability of frovatriptan for short–term prevention of menstrual migraine was similar to that observed with acute use of triptans. Adverse events were generally mild or moderate in severity, there was no evidence of an increased risk of cardiovascular adverse events relative to acute treatment, and rebound headache was not evident. A short–term regimen with frovatriptan presents a safe and viable treatment option for preventing predictable migraine such as menstrual migraine.

<< Previous
Systematic Review of the Literature on Pain in Patients with...

Next >>
Cytokine profile in elderly patients with sepsis

Increased Dopamine Is Associated With the cGMP and Homocysteine Pathway in Female Migraineurs
Headache: The Journal of Head and Face Pain, 10/07/09 Relevance Score: 86%

Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09 Relevance Score: 81%

Clinical and Economic Comparison of Frovatriptan Versus other Oral Triptans in the Treatment of Acute Migraine in the Real-World Setting
Clinical Drug Investigation, 10/15/09 Relevance Score: 81%

Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination
Current Medical Research and Opinion, 10/01/09 Relevance Score: 80%

Questionnaire Study on Menstrual Disorders in Adolescent Girls in Singapore
Journal of Pediatric and Adolescent Gynecology, 11/05/09 Relevance Score: 79%